The New Jersey Division of Mental Health and Addiction Services' (DMHAS) Medication Assisted Treatment Outreach Program (MATOP) seeks to provide accessible, comprehensive and integrated care, using evidence-based programs such as medication assisted treatment (MAT), mindfulness based recovery maintenance, smoking cessation and other recovery support services for individuals with an opioid use disorder. Three New Jersey licensed Opioid Treatment Programs (OTPs) will provide outreach to populations at risk such as incarcerated individuals, pregnant and parenting women, veterans, parents and caregivers involved with the child welfare system, opioid overdose reversals and syringe access program participants. New Jersey will focus efforts on Ocean, Essex, and Monmouth which demonstrated the highest number of opioid treatment admissions in 2013. The goals of MATOP are to: 1) increase individuals receiving MAT; 2) increase the individuals receiving integrated care and; 3) decrease illicit drug use at six-month follow-up. Specifically, MATOP seeks to: 1) increase understanding of MAT and address misunderstandings regarding the use of MAT among individuals and providers; 2) increase treatment admissions in New Jersey utilizing MAT; 3) demonstrate an increase in the rate of MAT patients who complete treatment; 4) demonstrate better outcomes through the use of MAT and additional supportive therapies and services; and 5) increase outreach to historically underserved populations. MATOP services to be provided include, but are not limited to: medical assessment, clinical assessment, physician visits, and wraparound/recovery support services. In addition, DMHAS will partner with other entities to provide trainings and webinar series for OTP providers, patients and their families. New Jersey's project will serve 390 unduplicated individuals total. Anticipated outcomes include but are not limited to a reduction/abstinence from drugs and alcohol and an increase in employment.